Add to ORKGAboriginal children in remote Australia have high rates of complicated middle ear disease associated with Streptococcus pneumoniae and other pathogens. We assessed the effectiveness of pneumococcal vaccination for prevention of otitis media in this setting
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living...
BACKGROUND: Aboriginal children in Northern Australia have a high burden of otitis media, driven by ...
© 2008 Leach et al; licensee BioMed Central Ltd. This is an Open Access article distributed under t...
© 2009 Mackenzie et al; licensee BioMed Central Ltd. This is an Open Access article distributed und...
Objectives: This study aims to monitor the prevalence of suppurative otitis media in remote Indigeno...
Background: The Australian Aboriginal population experiences disproportionately high rates of otitis...
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living...
BACKGROUND: We assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine efficacy (VE...
Background: In 2001 when 7-valent pneumococcal conjugate vaccine (PCV7) was introduced, almost all (...
BACKGROUND: In 2001 when 7-valent pneumococcal conjugate vaccine (PCV7) was introduced, almost all (...
Background: It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our ai...
AbstractBackgroundThe Australian Aboriginal population experiences disproportionately high rates of ...
AbstractBackgroundWe assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine effica...
Full list of author information is available at the end of the articleBackground Community based sur...
Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote are...
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living...
BACKGROUND: Aboriginal children in Northern Australia have a high burden of otitis media, driven by ...
© 2008 Leach et al; licensee BioMed Central Ltd. This is an Open Access article distributed under t...
© 2009 Mackenzie et al; licensee BioMed Central Ltd. This is an Open Access article distributed und...
Objectives: This study aims to monitor the prevalence of suppurative otitis media in remote Indigeno...
Background: The Australian Aboriginal population experiences disproportionately high rates of otitis...
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living...
BACKGROUND: We assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine efficacy (VE...
Background: In 2001 when 7-valent pneumococcal conjugate vaccine (PCV7) was introduced, almost all (...
BACKGROUND: In 2001 when 7-valent pneumococcal conjugate vaccine (PCV7) was introduced, almost all (...
Background: It is unclear why some children with acute otitis media (AOM) have poor outcomes. Our ai...
AbstractBackgroundThe Australian Aboriginal population experiences disproportionately high rates of ...
AbstractBackgroundWe assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine effica...
Full list of author information is available at the end of the articleBackground Community based sur...
Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote are...
INTRODUCTION: Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living...
BACKGROUND: Aboriginal children in Northern Australia have a high burden of otitis media, driven by ...
© 2008 Leach et al; licensee BioMed Central Ltd. This is an Open Access article distributed under t...